Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Steward

Showing results (211-220 of 256) with videos related to

Pageof 26
Sort By:
Cancer Chemotherapy and Pharmacology|July 8, 2005
Preliminary safety evaluation of the putative cancer chemopreventive agent tricin, a naturally occurring flavoneRichard D Verschoyle, Peter Greaves, Hong Cai, et al.
Molecular Biosystems|June 26, 2010
Plasma metabolic profiling reveals age-dependency of systemic effects of green tea polyphenols in mice with and without prostate cancerFriederike Teichert, Richard D Verschoyle, Peter Greaves, et al.
British Journal of Cancer|December 17, 2003
Measurements using the alkaline comet assay predict bladder cancer cell radiosensitivityM A L Moneef, B T Sherwood, K J Bowman, et al.
Cancer|February 1, 1988
Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma. A randomized prospective study with an assessment of prognostic factorsW P Steward, D Crowther, L J McWilliam, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphomaA M Seymour, E de Campos, N Thatcher, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2001
Bioavailability study of oral and intravenous OGT 719, a novel nucleoside analogue with preferential activity in the liverR A Sharma, M M Eatock, C J Twelves, et al.
British Journal of Cancer|June 1, 1984
A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma groupH Anderson, D P Deakin, J Wagstaff, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 7, 2009
A fuller understanding of pancreatic neuroendocrine tumours combined with aggressive management improves outcomeS L Ong, G Garcea, C A Pollard, et al.
British Journal of Cancer|February 5, 2004
Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbeneS Sale, R D Verschoyle, D Boocock, et al.
International Journal of Cancer|August 10, 2004
Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinomaSarah Donald, Richard D Verschoyle, Peter Greaves, et al.
Pageof 26

Showing results (211-220 of 256) with videos related to

Sort By:
Pageof 26
Cancer Chemotherapy and Pharmacology|July 8, 2005
Preliminary safety evaluation of the putative cancer chemopreventive agent tricin, a naturally occurring flavoneRichard D Verschoyle, Peter Greaves, Hong Cai, et al.
Molecular Biosystems|June 26, 2010
Plasma metabolic profiling reveals age-dependency of systemic effects of green tea polyphenols in mice with and without prostate cancerFriederike Teichert, Richard D Verschoyle, Peter Greaves, et al.
British Journal of Cancer|December 17, 2003
Measurements using the alkaline comet assay predict bladder cancer cell radiosensitivityM A L Moneef, B T Sherwood, K J Bowman, et al.
Cancer|February 1, 1988
Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma. A randomized prospective study with an assessment of prognostic factorsW P Steward, D Crowther, L J McWilliam, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphomaA M Seymour, E de Campos, N Thatcher, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2001
Bioavailability study of oral and intravenous OGT 719, a novel nucleoside analogue with preferential activity in the liverR A Sharma, M M Eatock, C J Twelves, et al.
British Journal of Cancer|June 1, 1984
A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma groupH Anderson, D P Deakin, J Wagstaff, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 7, 2009
A fuller understanding of pancreatic neuroendocrine tumours combined with aggressive management improves outcomeS L Ong, G Garcea, C A Pollard, et al.
British Journal of Cancer|February 5, 2004
Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbeneS Sale, R D Verschoyle, D Boocock, et al.
International Journal of Cancer|August 10, 2004
Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinomaSarah Donald, Richard D Verschoyle, Peter Greaves, et al.
Pageof 26